Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2010 Jun 1;16(12):1682–1692. doi: 10.1016/j.bbmt.2010.05.017

Table 6.

Series of multivariate regression models testing the association of demographic, clinical, and psychosocial factors with post-transplant physical and mental health

Factors PCS MCS

Model 1 Model 2 Model 3 Model 1 Model 2 Model 3

Beta Beta Beta Beta Beta Beta

Demographic and clinical variables at time of HCT
Age at HCT(Ref:
> 50)
< 35 4.10 ** 2.21 2.89* −3.42** −2.90* 0.14
35–39 3.04* 0.62 2.05 −3.43* −3.19* −0.71
40–44 2.82 1.41 2.41 −2.31 −2.16 0.67
45–49 2.05 1.78 2.15 −3.11* −2.78* −0.70
Race (Ref: White)
Other 3.32* 3.11* 3.09* 1.13 1.79 −0.54
Intensity of prior
treatment (Ref:
less)
More −2.35* −0.13 −0.19 0.03 0.04 0.12
HCT
comorbidities at
HCT (Ref: No)
Yes −2.22 0.98 1.00 −2.85* −2.04 −1.43
Demographic and clinical variables at time of study
Education at time
of study (Ref:
education beyond
bachelor’s degree)
High school or
below
0.24 1.02 0.82 0.49
Some college or
technical
education
−0.31 0.27 1.18 0.39
College degree 1.32 1.07 0.58 0.38
Family income at
time of study
occupational
status at time of
study (Ref:
>$80,000)
<$20,000 −5.04** −4.15** −5.02** −0.83
$20,000–40,000 −1.63 −1.08 −1.67 0.68
$40,000–60,000 −0.31 −0.39 −0.12 0.92
$60,000–80,000 1.09 1.07 −0.51 0.19
Occupational
status at time of
study (Ref:
Working or
student)
Not working −8.35*** −7.51*** −2.98* −0.22
Retired −3.36* −3.72** 2.63 1.86
Severity of HCT
experience (Ref:
low-autologous)
Intermediate
(allogeneic
without chronic
GVHD)
1.08 0.41 0.35 0.17
High (allogeneic
with chronic
GVHD)
−2.56* −2.65* 1.45 2.10*
HCT
comorbidities at
time of study
(Ref: No)
Yes −6.62*** −6.62 *** −0.97 0.39
Karnofsky score
at last follow up
0.28*** 0.28*** 0.11* −0.005
Psychological variables at time of study
Social constraint −0.27*** −0.11**
Spiritual well-
being
−0.08 0.25***
Social support −0.19** 0.10
Trait anxiety −0.13* −0.47***

Adjusted R2 3% 32% 36% 1% 7% 56%
*

P<0.05;

**

P<0.01;

***

P<0.001